Chen, H., Tu, H., Hu, Y., Fan, Y., Wu, G., Cang, S., . . . Wu, Y. A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001). BMC.
Chicago Style (17th ed.) CitationChen, Hua-Jun, et al. A Phase II Trial of Anlotinib Plus EGFR-TKIs in Advanced Non-small Cell Lung Cancer with Gradual, Oligo, or Potential Progression After EGFR-TKIs Treatment (CTONG-1803/ALTER-L001). BMC.
MLA (9th ed.) CitationChen, Hua-Jun, et al. A Phase II Trial of Anlotinib Plus EGFR-TKIs in Advanced Non-small Cell Lung Cancer with Gradual, Oligo, or Potential Progression After EGFR-TKIs Treatment (CTONG-1803/ALTER-L001). BMC.
Warning: These citations may not always be 100% accurate.